Disease progression model in subjects with mild cognitive impairment from the Alzheimer's disease neuroimaging initiative: CSF biomarkers predict population subtypes

AIM: The objective is to develop a semi-mechanistic disease progression model for mild cognitive impairment (MCI) subjects. The model aims to describe the longitudinal progression of ADAS-cog scores from the Alzheimer's disease neuroimaging initiative trial that had data from 198 MCI subjects w...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Samtani, Mahesh N, Raghavan, Nandini, Shi, Yingqi, Novak, Gerald, Farnum, Michael, Lobanov, Victor, Schultz, Tim, Yang, Eric, DiBernardo, Allitia, Narayan, Vaibhav A
Formato: Artigo
Idioma:Inglês
Publicado em: Blackwell Science Inc 2013
Assuntos:
Pharmacodynamics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3555054/
https://ncbi.nlm.nih.gov/pubmed/22534009
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2125.2012.04308.x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados